11

May

2022

To meet growing demand for its global services LOG, a leader in the pharma primary packaging industry, specialising in oxygen and moisture barrier solutions, is significantly expanding its manufacturing floor to increase capacity. The expansion includes the construction of a new multi-million-dollar ISO 8 cleanroom that will bring significant productivity benefits to its blue-chip customers […]

18

Jul

2021

Within this article, LOG presents insights about OTR testing and how it tests its oxygen-barrier packaging.

19

May

2021

Selecting the right bottle size for your pharmaceutical may be a daunting task. Here is a useful tool you might find helpful for choosing the right bottle size…

13

May

2021

Join the world’s leading stability experts at this year’s Science of Stability 2021 online conference. We are pleased to announce that Ora Tsoran, LOG’s VP of Barrier Technologies & Quality, and Tobias Eger, LOG’s VP of Marketing & Product will present in a poster session on the topic of “Modified Atmosphere Packaging – Solutions for […]

11

May

2021

We are excited to announce that on June 9th we will be hosting episode 2 of our webinar series on The Science of Barrier Packaging, choosing the optimal packaging design for your moisture-sensitive formulations. In episode 2, our leading pharma packaging experts will be sharing cutting-edge research, insights, and solutions…

26

Apr

2021

LOG Pharma Primary Packaging continues to pave the way as a leader in the pharmaceutical primary packaging market with its cutting-edge developments in barrier packaging, receiving second-place honors at the Kinneret Innovation Center’s Hybrid Innovation Hackathon.

1

Mar

2021

LOG’s MonoBlock® barrier packaging solution offers outstanding barrier protection for moisture-sensitive formulations and is commercially used by global pharmaceutical manufacturers. Based on WVTR (Water Vapor Transmission Rate) test results performed on 60ml bottles, MonoBlock® has an up to 4x greater moisture barrier…

12

Feb

2021

LOG’s OxyBlock® barrier packaging solution which is endorsed and used by global pharmaceutical companies for the last 10 years, offers outstanding barrier protection for formulations sensitive to oxygen such as Atorvastatin, Aspirin-Dipyridamole, etc… Based on OTR (Oxygen Transmission Rate) test results performed on 60ml bottles…

3

Dec

2020

LOG Pharma Primary Packaging continues to pave the way as a leader in the pharmaceutical primary packaging market with its cutting-edge developments in barrier packaging, receiving second-place honors at the Kinneret Innovation Center’s Hybrid Innovation Hackathon.

15

May

2020

As additional drugs in the pharmaceutical market commercially launch with LOG’s barrier packaging products, LOG Pharma Primary Packaging has expanded the production capacity of its innovative multilayer pharma barrier products, the OxyBlock® and MultiBlock® product families.

21

Jan

2020

LOG Pharma’s innovative smart packaging solution addresses the widespread lack of patient adherence to prescription medicine or supplementation of nutraceuticals by harnessing the power of IoT technology to increase patient engagement. Low and inconsistent adherence is responsible for 33% of medicine-related hospitalizations, an estimated 125K deaths every year in the US alone, and $300B in […]

3

Dec

2019

The Challenge Paliperidone is an antipsychotic drug commonly used to treat schizophrenia. Its novel extended-release formulation makes it therapeutically ideal for treatment of psychotic disorders but presents a significant packing challenge for pharmaceutical companies.   Paliperidone is extremely sensitive to oxygen degradation, posing challenges to the drug’s stability throughout the duration of its entire shelf […]